PaxMedica, Inc.

/PaxMedica, Inc.

IPO

PaxMedica, Inc.

Biopharmaceutical

Early clinical stage biopharmaceutical company focusing on the development of anti-purinergic therapies (or APT), for the treatment of neurodevelopmental disorders, including autism spectrum disorder (or ASD), and Fragile X tremor-ataxia syndrome (or FXTAS).

Symbol

PXMD

Price Range
$5.50 - $6.50

Final Shares
2,500,000

Anticipated Date
September 23, 2020

Underwriters
THE BENCHMARK COMPANY, LLC

This offering is orderable

To view the prospectus for PaxMedica, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277